| |
| |
|
| Insider
Information: |
Williams Douglas E |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
136,733 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,315,957 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,733 |
|
|
| Total
Value |
$3,315,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2007-09-04 |
4,500 |
|
0 |
Premium* |
|
|
Zymogenetics Inc |
ZGEN |
Chief Executive Office... |
2010-10-08 |
0 |
2007-09-04 |
0 |
Premium* |
|
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2013-06-09 |
19,961 |
2009-12-04 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
EVP Research & Develop... |
2015-06-19 |
11,817 |
|
0 |
Premium* |
|
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2019-04-01 |
87,800 |
2014-06-03 |
0 |
Premium* |
|
|
Ovid Therapeutics Inc. |
OVID |
Director |
2018-08-14 |
5,000 |
2018-08-14 |
0 |
Premium* |
|
|
Codiak Biosciences, Inc. |
CDAK |
|
2023-03-28 |
7,655 |
2020-10-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2004-08-25 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-09-04 |
4 |
B |
$2.36 |
$4,720 |
D/D |
2,000 |
4,500 |
2.31 |
- |
|
| ZGEN |
Zymogenetics Inc |
President and CSO |
• – – |
2007-09-04 |
4 |
B |
$12.25 |
$24,500 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| ZGEN |
Zymogenetics Inc |
President and CSO |
• – – |
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100 |
2,100 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
President and CSO |
• – – |
2008-02-20 |
4 |
B |
$8.99 |
$22,475 |
D/D |
2,500 |
4,600 |
2.74 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2009-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,185 |
6,185 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2010-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,086 |
14,271 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Chief Executive Officer |
• • – |
2010-10-08 |
4 |
D |
$9.75 |
$44,850 |
D/D |
(4,600) |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & DevelopmentOffi |
• – – |
2011-01-10 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
403 |
|
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,538 |
18,809 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2011-12-04 |
4 |
D |
$6.86 |
$10,606 |
D/D |
(1,546) |
17,263 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• – – |
2012-02-01 |
4 |
D |
$121.26 |
$200,807 |
D/D |
(1,656) |
3,906 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• – – |
2012-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
5,562 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2012-03-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,320) |
14,943 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2012-06-03 |
4 |
D |
$3.51 |
$7,094 |
D/D |
(2,021) |
12,922 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2012-06-07 |
4 |
A |
$3.67 |
$29,999 |
D/D |
8,174 |
21,096 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
8,864 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2013-02-01 |
4 |
D |
$157.30 |
$264,107 |
D/D |
(1,679) |
7,185 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2013-02-08 |
4 |
D |
$164.44 |
$205,879 |
D/D |
(1,252) |
8,939 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2013-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,006 |
10,191 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2013-06-09 |
4 |
D |
$1.86 |
$2,111 |
D/D |
(1,135) |
19,961 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2013-08-26 |
4 |
AS |
$211.35 |
$923,168 |
D/D |
(4,368) |
4,571 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2014-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
9,730 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2014-02-01 |
4 |
D |
$312.64 |
$615,588 |
D/D |
(1,969) |
7,761 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Research & Development |
• • – |
2014-02-08 |
4 |
D |
$315.54 |
$516,223 |
D/D |
(1,636) |
9,593 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
